Method for making preparation of jagel-m with antituberculous action

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely to a preparation with antituberculous action. The method for making the preparation with antituberculous action, characterised by that a dried blastema of sort Cladonia is mechanically treated with solid sodium alkali added. The prepared dry mixture is drawn in an aqueous-alcoholic mixture under certain conditions. The solution is separated from sediment by centrifugation and neutralised with citric acid.

EFFECT: produced preparation shows improved antituberculous action.

1 dwg


The invention relates to the biopharmaceutical industry, namely the production of Biologicals anti-TB activity. The use of mechanochemical technologies in the technological cycle of production of antibiotic from the thalli of lichens at the stage of processing of dry materials and the subsequent water-alcohol extraction allow to allocate more complete group of natural substances with antibiotic activity (PVAD).

Lichens of the genus Cladina (Cladonia) - medicinal plants used in folk medicine for treatment of many diseases. In the thalli of lichens contain up to 80% carbohydrates, half of which is represented by homopolysaccharides latinam and selegiline with as immunomodulatory, anticancer and hepatoprotective properties

Aware of the use of lichens as antibiotic funds. So, antimicrobial antibiotic activity against staphylococci, streptococci, acid-fast bacilli, fungi, protozoa and viruses due to the presence in the thalli of the lichen acids [Galitsky L.A., etc. // Probl. the tubes. - 1997. No. 4. - P.35-38], first of all, usninovoy acid (Fig.) and its derivatives [Gorshkov R.P., etc. // Bioorgan. chemistry. - 1997. - Volume 23, No. 2. - S-1328].

Fig. The General formula STS the new acid.

Obtained from lichens usnic acid in the form of usniate sodium was proposed under the name of "Binan" for medical use and was used as an external tool for the treatment of wounds, burns, fractures and gynecology. With the advent of synthetic and semi-synthetic antibiotics drug was discontinued [Teletel VV Useful plants of Central Siberia. - Irkutsk. - 1987. - P.21-22].

The closest analogue of the present invention (the prototype) is the anti-TB drug with a wide spectrum of pharmacological action ISlate" (dry extract of the thalli tsetrarii Icelandic), which has tonic, anti-inflammatory, antimicrobial, antihypoxic, immunomodulatory, hepatoprotective and antioxidant effects [Vitovsky M. etc. the Role of Isleta (extract of the thalli tsetrarii Icelandic) in the treatment of experimental tuberculosis // Problems of tuberculosis and lung diseases: monthly scientific-practical magazine /Russian society of TB (M). - 2005. - N11. - P.44-47; Pat No.2203081 RF Drug iSlate for the prevention and treatment of tuberculosis and how to obtain it./ Lesiovskaja E.E. and others}.

The technical effect of the invention is an antibacterial drug LICHEN-M, characterized by an increased activity against the AI pathogens first of all, mycobacteria (tubercle Bacillus).

The effect is achieved by the fact that the use of mechanochemical treatment of lichen raw material in the presence of alkali leads to the transfer of water-insoluble flavonoids group usanovich and other lichen acids in the soluble state.

The essence of the invention lies in the fact that preextraction processing of dry thalli of lichens using mechanochemical technology with the addition of dry alkali can allocate more full group PVAD due to poorly soluble in water and water-alcohol mixtures of aromatic phenols (Fig.) in the well-soluble reaction. This ensures maximum extraction of all the structural spectrum of active substances, which also does not allow to form the reaction of microbial resistance to this antibiotic complex.

The invention can be implemented as follows.

The dried thallus of lichens of the genus Cladina {Cladonid} is subjected to mechanochemical treatment in a ball mill (for example, AGO-2) in the presence of solid alkali sodium at 1500 rpm Obtained dry mixture insist on 40%of water-alcohol mixture within 7 days, the solution is separated from the precipitate by centrifugation (filtered under pressure) and neutralized to a pH of 6.9-7.0 and citric acid.

Antibacterial the Noah effect of the drug LICHEN-M against opportunistic, pathogens and Mycobacterium tuberculosis (MBT) is proved in experiments on cultures of bacterial strains and outbred white mice by standard methods.

Investigated the influence

complex lichen PVAD on cultures of bacterial strains eight conditionally pathogenic and pathogenic microorganisms;

- extract of the thalli of lichens on the biological properties of the ILO in vitro, including with drug resistance to anti-TB drugs (PTP);

complex lichen PVAD on the course of experimental tuberculosis in outbred white mice.

Comparative study of antibacterial action of 40% aqueous-alcoholic extract of the thalli of lichens without prior mechanochemical processing (extract # 1) and drug LICHEN-M (table 1).

Shows the full lytic ability of the drug LICHEN-M in relation to eight of conditionally pathogenic and pathogenic bacterial strains, including Staphylococus aureus, Klebsiella pneumoniae, hemolytic E. coli and other (table 1), whereas the extract No. 1 showed high efficacy only against Proteus vulgaris. In other cases, or barely noticeable attempt to lysis, or the microorganisms were visualized in part.

In order to study the antibacterial activities of the extracts of lichens No. 1 and drug LICHEN-M the and biological properties of the ILO conducted a pilot study on the clinical strains office No. 691, sensitive to PTP, and No. 742 resistant to streptomycin at a concentration of 25 μg/ml, isoniazid concentration of 1 µg/ml, rifampicin 80 ág/ml (table 2 and 3).

Determination of activity of antibacterial action of the tested lichen extracts was performed by the method of serial dilutions on solid nutrient media in a ratio of from 1:1 to 1:512. As the nutrient medium used traditional nutritious egg medium for growing office - Finn-2 (f-2). The effectiveness of antibacterial action of lichen extracts was determined by the appearance of the primary, intensive and massive growth of the cultures of the office.

Under the action of extract No. 1 on the clinical strains No. 691 and 742 in dilutions 1:1, 1:2 and 1:4 reported no growth of mycobacteria in the environment (bactericidal effect). In a dilution of 1:8 is the delay in initial and intensive growth compared with the control culture. A dilution of 1:16 has on the office moderate bacteriostatic effect (table 2 and 3).

Drug LICHEN-M in dilutions 1:1, 1:2 and 1:4 also has a bactericidal effect on the office of clinical strain No. 691 (table 4). A dilution of 1:8 bacteriostatic action. Weak bacteriostatic effect dilution of 1:16 and 1:32 with delay in initial and intensive growth for 6 days and increased to 100 CFU compared with the control. Bactericidal action is e drug LICHEN-m on the clinical strain No. 742 was observed at dilutions 1:1, 1:2, 1:4 and 1:8. Starting with a dilution of 1:16, there is a delay in initial and intensive growth of the office by 7 and 6 days, respectively, with poor growth of up to 20 KOE. Therefore, the drug LICHEN-M in a dilution of 1:16 has a marked inhibitory effect on the office (table 5).

Determination of specific activity of the extracts on the course of experimental tuberculosis was carried out on 18 outbred white mice weighing 13-16 g, obtained from the vivarium of the Yakut Republican veterinary testing laboratories. The mice were infected with introduction into the skin of the back suspension (0.1 mg bacterial mass in 0.5 ml saline) three-week culture of clinical MBT strain No. 238 multidrug resistance. Study the extracts were injected into mice inside from the day of their infection.

All experimental animals were divided into following groups of 6 animals in each group: group 1 - infected animals (infection control) no treatment; group 2 - infected animals receiving the extract of the lichen No. 1 in a dilution of 1:8; 3rd group - infected animals receiving the drug LICHEN-M in a dilution of 1:8. The duration of the experiment was 2.5 months, surviving to this time the animals were killed.

The main indicators of resistance of the animal to the TB is the duration of survival after inficon the cation and the General condition of the animals.

Mortality of mice of the 1st group (control of infection), not treated, amounted for the period of the experiment 100%. The death of the mice was observed in the period from 20 to 73 days, the average life expectancy was 39 days, which indicates the high virulence of the used culture of the office. Total body weight loss in this group was 32%. In mice the 2nd group mortality for the period of the experiment was 50%, with an average life expectancy of 51.5 days. Total body weight loss in this group was 8%. In mice 3rd group receiving the drug LICHEN-M, mortality was during the period of the experiment 16.6% (in the course of the experiment died 1 mouse in the 73rd day of the experiment). The total body weight of the animals in this group increased by 2.5 g (16-19%).

Therefore, demonstrated very high efficacy MOSS-M in relation to conditionally pathogenic and pathogenic bacterial strains, including Staphylococus aureus, Klebsiella pneumoniae, hemolytic E. coli, Salmonella enteridis and others, even their drug-resistant forms, as well as against mycobacterial strains sensitive and resistant to anti-TB drugs. Set high antimycobacterial drug activity MOSS-M when used in the treatment of experimental tuberculosis in vivo led to a sharp reduction in severity of infection in mice, INF is different office.

A method of producing a drug that has anti-TB activity, characterized in that the dried thallus of the lichen genus Cladina (Cladonia) is treated mechanically in the presence of solid alkali sodium obtained dry mixture is soaked in a 40%water-alcohol mixture within 7 days, the solution is separated from the precipitate by centrifugation, neutralize citric acid.


Same patents:

FIELD: medicine.

SUBSTANCE: method for making a medicated food additive of marine macrophyte algae wherein dry and/or wet ground macrophyte is rinsed with distilled water with ozone added; further the mixture is proportioned in a rotor homogeniser with sodium alginate introduced; homogenisation is carried out with distilled water supplied, under certain conditions.

EFFECT: medicated additive of higher purity and reduced cost price.

3 cl, 1 dwg, 8 ex

FIELD: physics.

SUBSTANCE: invention is meant for extraction using a vacuum and can be used for extracting biologically active components from plant, animal, fish material, seafood, used in the food and pharmaceutical industry. The proposed extraction method involves heating an extraction agent to temperature at which the material and the obtained product are denatured. Before vacuum-pulsed saturation, the material is extracted on heated rollers with modulus (extraction agent : material) not greater than 2. The extraction agent used is distilled water or aqueous alcohol solution with alcohol concentration of not less than 20%. The extract is subjected to vacuum-pulsed filtration. After filtration low-temperature evaporation is carried out in thermo-vacuum-pulsed mode. Essential oils of the extract are trapped and separated from water vapour in condensers and water droplets falling in pipes are trapped by a drop catcher. The device for extracting materials includes a screw doser and continuous heated rollers with a container for receiving pulp saturated with extraction agent, two vacuum filters, extract collector, drop catcher, two condensers, foam remover, receiver and two extractors.

EFFECT: more efficient extraction process while reducing extraction agent costs, higher quality and output of extracted components.

7 cl, 1 dwg

FIELD: medicine.

SUBSTANCE: invention refers to chemical-pharmaceutical, medical and cosmetic industry. Tillet blossom is grinded and extracted in distilled water with 0.1% NaOH and 10% zinc sulphate and exposed to ultrasound at frequency 30 kHz and intensity of 45+55 Wt/cm, filtered to produce extracted polysaccharide complex there after dried. Ultrasound exposure time is 18-22 minutes. Extraction process is carried out at temperature 23÷25°C.

EFFECT: invention allows improving product yield.

2 cl, 3 dwg, 3 ex

FIELD: medicine.

SUBSTANCE: invention refers to chemical-pharmaceutical and medical industry. Common valerian roots and rhizomes are extracted in 70% ethyl alcohol with following filtration of the extract from herbal raw material. Extraction is aided with ultrasonic waves of frequency 30 kHz and intensity 365-370 Wt/cm2 during 18-20 minutes at temperature 25-27°C at the relation of herbal raw material to 70% ethyl alcohol as 1:10.

EFFECT: invention allows improving yield and reducing preparation time of the product.

2 cl, 1 dwg, 1 tbl, 1 ex

FIELD: agriculture.

SUBSTANCE: air-dry crushed wood greens of fir is extracted twice with tret-butylmethyl ester. Extract is separated from needles and treated with 2% NaOH solution with further separation of organic and water layers. Water-alkali layer is acidified and formed organic phase representing sum of triterpene acids is separated. Organic layer is concentrated by extragent distillation, treates with hot water and volatile agents of fir oil are hydrodistilled at under pressure 0.1-0.3 atm and temperature not higher than 50°C. Vat residue is hydrolysed by boiling with water-alcohol alkali and neutral hydrolysate components are separated by solvent distillation at lowered pressure and temperature not higher than 80°C with further double extraction with methyl-tret-butyl ester, 2-3-time washing of obtained layer with water to neutral reaction and evaporation. Water-alcohol solution is acidified with 5-10% solution of hydrochloric acid to pH 2 and extracted with tret-butylmethyl ester. Extract is washed with water to neutral pH and ester is distilled under pressure 0.1-0.3 atm and temperature not higher than 80°C obtaining the product.

EFFECT: invention allows to realise said purpose.

7 ex, 6 tbl

FIELD: medicine.

SUBSTANCE: raw material is grinded that is followed with vacuum ultrasonic extraction with 80% ethyl alcohol at 18-20°C.

EFFECT: invention allows simplifying the process and improving product purity.

1 ex

FIELD: chemistry.

SUBSTANCE: invention relates to household chemistry, medicine, cosmetic-fragrance industry. Material is extracted using aqueous propyleneglycol extracting agent in a rotor-pulse apparatus without presoaking in continuous circulation mode with ratio of plant material to extraction agent ranging from 1:10 to 1:20 and rotor speed of 3600 to 4400 rpm for 5 to 15 minutes at 25 to 55°C with subsequent filtering off the solid plant part. 1,2-propyleneglycol with water content ranging from 0.1 to 95 wt % is used.

EFFECT: invention allows for cutting on extraction time and obtaining extract with high content of flavonoids (by 20 to 40%) and high resistance to microbiological pollution.

2 cl, 3 tbl, 20 ex

FIELD: chemistry.

SUBSTANCE: invention relates to the chemical and pharmaceutical industry. Schizandra seeds are extracted using 70-90% ethyl alcohol first at room temperature and then while heating at temperature between 65-70°C.

EFFECT: invention increases output of active substances.

2 ex, 1 tbl, 1 dwg

FIELD: wood working industry.

SUBSTANCE: invention relates to wood chemical industry. Waste wood of aspen is chopped till particle size is less than 1 mm, is dried on air till moisture content is not more than 18%, raw material is watered at a temperature of 18-25°C with the following ratio of the raw material: extractant = 1:1.5-2.5, within 10-24 hours, further mechanical pressing of extractant and concentrating it in a vacuum at a temperature of not higher than 40°C till content of total solids is from 3.5 to 100%.

EFFECT: invention allows fulfilling the specified purpose.

10 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: method for making cream-gel of celandine extract includes selection of fresh blooming and fruit ripening plants, then milled to vegetation debris, put into an opaque container with glass walls and kept under certain conditions. During this period, fogging-off plants are irrigated once or twice with a standard end extract from previous collections. Then the whole debris is filled in with boiled water and further fermented (liquid phase) to eliminate smell. Liquid is separated from vegetation debris, spilled in an ajar glass, kept under certain conditions, at first filtered through the usual filter, and then through the ultrafilter membrane, added to a liquid crystal cream-gel base.

EFFECT: cream-gel of celandine extract with effective therapeutic action.

2 cl, 1 ex

FIELD: medicine.

SUBSTANCE: invention is related to composition with high tuberculostatic activity.

EFFECT: reduced toxicity and by-effects of its components.

1 cl, 1 ex, 4 tbl

FIELD: medicine.

SUBSTANCE: for treatment of pulmonary tuberculosis in HIV-infected patients carried out is anti-tuberculosis therapy according to standard schedules. Additionally since first day of treatment galavit is administered intramuscularly in dose 100 mg one time per 3 days. On the whole 15 injections are made. Addition of galavit to treatment, with given schedule and duration of introduction, produces normalising effect on imbalance of cellular and humoral immune response in patients with HIV-associated tuberculosis.

EFFECT: increase of treatment efficiency due to reduction of abacillation terms and closing of disintegration cavities, resolution of infiltrative changes in lungs.

2 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used for treating pulmonary tuberculosis in HIV-patients. That is ensured by performed tuberculous therapy according to standard conditions. In addition, from the first day and upon termination of the therapeutic course, Wobenzym in dose 3 tablets 3 times a day 30 minutes before meals daily is prescribed.

EFFECT: therapeutic addition of Wobenzym in a specially developed dose and schedule makes a normalising effect on imbalanced cell and antibody response in the patients of the given category that allows improving clinical effectiveness ensured by shorter abacilliation and closure of destruction cavities, resorption of infiltrative changes in lungs.

2 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to phthisiology, and can be used in treating the patients with pulmonary tuberculosis. That is ensured by conventional tuberculous therapy. The therapeutic course includes Viferon, rectal suppositories containing 1000000 ME of human recombinant alpha-2 interferon. Viferon is dosed one suppository twice day, every 12 hours, the 1st to 10th day - daily and the 11th to 60th day - every second day.

EFFECT: therapeutic addition of Viferon in treating tuberculosis in specially developed dose and schedule allows improving clinical effectiveness ensured by reduced abacillation time and closure of decomposition cavities, resolution of infiltrative pulmonary changes.

2 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: according to the invention, the method provides combined cultivation of nonadherent fraction of mononuclear cells (MNCs) recovered from peripheral blood of the patients with pulmonary tuberculosis, with dendritic cells (DCs) processed with the antigen Mycobacterium tuberculosis and prepared of monocytes of adherent MNC fraction with using mature DCs being prepared by adding a maturing inducer representing lipopolysaccharide E coli to antigen-activated immature DCs. The combined cultivation of specified cells is carried out with recombinant human interleukine-18 (IL-18) added.

EFFECT: intensified proliferative potential of specific cytotoxic cells of mononuclear origins, stimulation of IFN -γ production level, formation of cytotoxic cells in response to the specific antigen M tuberculosis.

3 tbl

FIELD: medicine.

SUBSTANCE: invention concerns method for preparing autologous tuberculosis vaccines. Substance of the invention consists in activation in vitro of mononuclear fractions of leukocyte recovered from the patient's blood of the patient suffering from tuberculosis by bedding on density gradient of Ficoll urographine. After centrifugation, mononuclear leukocytes collected from interphase are washed, resuspended in a culture medium DMEM environment and cultivated therein with tuberculine and Roncoleukine added. Then cells are counted, diluted to concentration 2 million cells per ml and cultivated at 5% carbon dioxide concentration. Then cells are resuspended in physiologic saline with Roncoleukine.

EFFECT: application of the method allows preparing high-effective autologous tuberculosis vaccine.

3 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention concerns medicine and pharmacology and concerns application of 6-oxy-2,2,4-trimethyl-1,2-dihydroquinoline or 6-oxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline as a high-effective tuberculous substance.

EFFECT: there is disclosed application of 6-oxy-2,2,4-trimethyl-1,2-dihydroquinoline or 6-oxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline as a tuberculous substance.

1 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medical products, particularly to pharmaceutical tuberculosis composition containing isoniazid conjugate with oxidised dextrane of molecular weight 35-60 kDa purified from free isoniasid and cytotoxic impurities, e.g. by spirit sedimentation at temperature 60-80°C. Additionally, the pharmaceutical composition contains a liposome-forming agent, e.g. phosphatidylcholine, pharmaceutically acceptable excipient, e.g. water for injection, saline or buffer solution. The component ratio is as follows: isoniasid conjugate with oxidised dextrane - 0.4-4.0 wt %, the liposome-forming agent - 0.1-1.0 wt %, the pharmaceutically acceptable excipient - to 100 wt %. The pharmaceutical composition represents nanoliposome emulsions of liposome size 150-800 nm.

EFFECT: lower hepatotoxicity and improved biocompatibility.

5 cl, 2 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention concerns medicine, particularly phthisiourology and covers prevention of development of microcystitis in patients suffering from cystic tuberculosis. It is ensured by introduction of isoniasid by indirect lymphotropic technique through forming a local lymphostasis. Rifampicin is introduced in microclyster as a component of the medicinal cocktail containing Novocaine 0.5% 50 ml + Rifampicin 0.6 g + dimexid 5 ml. In addition, spasmex is prescribed in a dose 15 mg twice a day within 3 months.

EFFECT: providing good tolerance, the method enables stable relief of dysuria, increase of bladder capacity and effective prevention of apparent microcyst.

2 dwg, 2 tbl, 1 ex

FIELD: chemistry.

SUBSTANCE: in formula compounds, each of R1, R2, R3, R4 is a substitute for a cyclic system, chosen from hydrogen, halogen, C1-C6-alkyl; C1-C6-alkoxy group; X is a heteroatom, chosen from oxygen or sulphur; R5 and R6 independently represent amino group substitutes, chosen from hydrogen, possibly substituted C1-C6-alkyl; possibly substituted C3-C6-cycloalkyl, which can be annealed with a benzene ring; possibly substituted phenyl, which can be annealed with dioxole, dioxine, -(CH2)n group, where n=4 to 6, or with a 5 or 6-member possibly substituted and possibly condensed azaheterocyclyl; possibly substituted saturated or unsaturated 5-6-member heterocyclyl, containing 1-2 heteroatoms, chosen form nitrogen, oxygen, sulphur and possibly condensed with a benzene ring, or R5 and R6 together with the nitrogen atom to which they are bonded, form an optionally substituted 5 or 6-member azahetero ring, possibly containing an additional heteroatom, chosen from nitrogen, and possibly annealed with a benzene ring or spiro-condensed with dioxole, where substitutes in the said alkyl, cycloalkyl, phenyl and heterocyclyl are chosen from halogen atoms, possibly substituted C1-C6-alkyl, CF3, possibly substituted C3-C6-cycloalkyl, possibly substituted phenyl, 5 or 6-member heterocyclyl, nitro group, substituted amino group, alkyloxycarbonyl, substituted carbonyl, aminocarbonyl, alkylsulphanyl.

EFFECT: design of an efficient method of producing new substituted furo[2,3-b]quinoline-2-carboxamides and substituted thieno[2,3-b]quinoline-2-carboxamides or their racemates, or their optical isomers, as well as their pharmaceutically acceptable salts and/or hydrates of general formula (I), which have antituberculous activity.

9 cl, 1 dwg, 7 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: offered composition contains: (a) peroxide complex containing hydrogen peroxide and N-vinyl-heterocyclic polymer (e.g., poly-N-vinylpolylactam or poly-N-vinylpolyimid); (b) a wightening agent (e.g., hydrogen peroxide); and (c) an orally acceptable carrier containing silicone polymer, chosen from the group consisting of silicone adhesives, silicone elastomers, silicone liquids, silicone resins, silicone rubbers and their mixtures. The method for making the oral care composition involves the stage as follows: (a) mixing the wightening agent, silicone adhesive and a liquid carrier to a homogeneous mixture; (b) adding peroxide complex to said homogeneous mixture where said complex contains hydrogen peroxide and N-vinyl-heterocyclic polymer; and (c) mixing under suction.

EFFECT: oral care composition provides higher accessible concentration of the wigthening agent, teeth adhesion in presence of saliva without using a dental tray, and eventual release of the wightening agent.

22 cl, 3 tbl, 3 ex